Does the bilirubin component of the SOFA score risk mislabeling patients as septic, and is a documented infection required for the score to indicate sepsis?

Sepsis, SOFA, and Bilirubin: Do we mislabel patients?

No—SOFA (including its bilirubin component) alone does not diagnose sepsis; you still need suspected or documented infection, and organ dysfunction from any cause (e.g., chronic liver disease) should not be labeled sepsis without infection. 1, 2

• Framework (highest‑quality, most recent guidance first)

  • Sepsis-3: Sepsis = life‑threatening organ dysfunction caused by a dysregulated host response to infection; operationalized as ΔSOFA ≥2 with suspected/confirmed infection. SOFA is an organ‑dysfunction score, not a sepsis test. Infection is required. 1
  • Surgical/acute care guidance aligns: Use SOFA to quantify organ dysfunction after identifying likely infection; qSOFA only screens risk. 2
  • NICE (2024): Start with suspected/confirmed infection plus physiologic risk (NEWS2), not labs alone; avoid overtreatment when infection likelihood is low. This protects morbidity/mortality/QoL by preventing both missed sepsis and antibiotic harm. 3

• Bilirubin within SOFA: risk of “mislabeling”

  • Elevated bilirubin increases SOFA but does not equal sepsis. In cholestasis, cirrhosis, hemolysis, or drug injury, bilirubin may be high absent infection—these should not be called sepsis without infection. 1
  • Pitfall to avoid: attributing hyperbilirubinemia to “sepsis liver” when baseline hepatic disease exists (e.g., decompensated cirrhosis). Use clinical context; CLIF-SOFA is the appropriate liver-specific tool in cirrhosis/ACLF, not sepsis labeling per se. 4
  • Practical nuance: SIC/DIC guidance also requires sepsis first (SOFA ≥2 due to infection) before applying coagulation scores; liver dysfunction can confound PT/platelets—another reason not to label sepsis on labs alone. 5

• Algorithm (to minimize morbidity, mortality, and QOL harm)

  1. Suspect/confirm infection:
     • Source evidence (e.g., pneumonia, UTI, IAI), positive cultures, imaging, purulence, or strong clinical syndrome. Use NEWS2/qSOFA to risk-stratify urgency; do not proceed on SOFA alone. 3, 1
  2. Calculate SOFA only after step 1:
     • If ΔSOFA ≥2 AND infection suspected/confirmed → sepsis present. 1
     • If ΔSOFA ≥2 but infection unlikely/absent → organ dysfunction from noninfectious cause; do not label sepsis. Reassess for noninfectious etiologies (cirrhosis, biliary obstruction, hemolysis, drug‑induced cholestasis). 1, 4
  3. Interpreting bilirubin:
     • If bilirubin drives SOFA increase:
       • Check baseline liver history, cholestatic pattern, hemolysis labs, imaging. If noninfectious cause likely, do not call sepsis. 1, 4
       • If concurrent credible infection plus other organ dysfunction (e.g., hypotension, AKI) → treat sepsis promptly per risk tier to reduce mortality. 3, 1
  4. Reassess frequently:
     • If initial infection likelihood low but evolves to likely (new fever, purulence, positive cultures), reclassify and treat per sepsis timelines to protect outcomes. 3

• Common pitfalls and how to avoid them

  • Pitfall: Using SOFA (or bilirubin) as a stand‑alone sepsis diagnosis. Avoid by requiring suspected/confirmed infection first. 1
  • Pitfall: Misclassifying cirrhotics with baseline hyperbilirubinemia as septic. Use CLIF‑SOFA where appropriate; seek new infection evidence before sepsis labeling. 4
  • Pitfall: Over-treating low‑likelihood infection on the basis of bilirubin alone. Follow NICE time windows by risk tier to balance mortality benefit vs antibiotic harms. 3
  • Pitfall: Applying SIC/DIC scores without established infection; remember SIC presupposes sepsis and has low specificity—do not let coagulopathy or bilirubin changes alone drive the sepsis diagnosis. 5

• Bottom line for labeling

  • Yes, bilirubin can inflate SOFA and would “mislabel” patients as septic if you ignore the prerequisite of infection—but Sepsis‑3 explicitly prevents this by requiring suspected/confirmed infection plus ΔSOFA ≥2. Keep infection first, SOFA second. 1, 2